Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate Control
(1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the development of bioactive molecules, contributing to research in medicinal chemistry and drug formulation. Its structural characteristics make it an essential reagent for the synthesis of various therapeutic agents. -
Drug Impurity
Rosuvastatin impurity 23 is a drug impurity associated with the statin medication Rosuvastatin, which targets HMG-CoA reductase. This compound is primarily used in pharmaceutical research to assess the purity and quality of Rosuvastatin formulations, ensuring compliance with regulatory standards. Its characterization is vital for studies focused on the safety and pharmacokinetics of statin therapies. -
Drug Impurity
Terbinafine impurity 4 is a known impurity of the antifungal agent Terbinafine. It is primarily used in analytical research to assess the purity and quality of Terbinafine formulations. This compound can facilitate the study of drug stability, degradation pathways, and the identification of potential side effects related to impurities in drug development and manufacturing processes. -
Drug Impurity
Afatinib impurity 32 is a characterized impurity of Afatinib, a selective inhibitor of the ErbB family of receptor tyrosine kinases. This compound is primarily utilized in the quality control and analytical studies related to Afatinib production. Its presence can provide insight into the synthetic pathway and aid in ensuring the purity and potency of the final drug product. -
Drug Impurity
Cetirizine Impurity 14 is a chemical compound classified as a drug impurity associated with the antihistamine cetirizine. This impurity may play a role in assessing the purity and stability of cetirizine formulations during pharmaceutical development. Its presence can provide insights into the synthesis process and help in regulatory compliance for drug quality control. -
Drug Impurity
Clindamycin palmitate impurity 6 (Clindamycin B palmitate) is a drug impurity characterized by its specific structural modifications to clindamycin. It serves as a quality control standard in the analysis of clindamycin formulations to ensure safety and efficacy. This compound is relevant for researchers investigating drug purity and the effects of impurities on biological activity and pharmacokinetics. -
Drug Impurity
Solifenacin impurity 6, a known impurity of Solifenacin, serves as a critical reagent for analytical chemistry applications. This compound is essential for ensuring the purity and safety of Solifenacin formulations during quality control processes. Its characterization and quantification are vital in pharmacological studies and regulatory assessments, contributing to the overall understanding of Solifenacin's chemical profile. -
Drug Impurity
Acyclovir impurity 3, also known as Acyclovir N-methylene dimer, is a drug impurity associated with Acyclovir synthesis. Its presence in pharmaceutical formulations can influence the safety and efficacy profiles of Acyclovir. This compound is utilized in stability studies and quality control assessments to ensure the purity of drug formulations in research and development settings. -
Drug Impurity
Lornoxicam impurity 16 serves as a recognized impurity of Lornoxicam, a non-steroidal anti-inflammatory drug (NSAID). Its characterization is crucial for assessing the purity and safety profiles of pharmaceutical formulations containing Lornoxicam. This compound is utilized in research applications focusing on drug formulation development and quality control within the pharmaceutical industry. -
Drug Impurity
Olaparib impurity 22 is a characterized impurity of the PARP inhibitor Olaparib. This compound is essential for quality control and analytical studies in drug development, particularly in assessing the purity and stability of Olaparib formulations. Its presence can influence therapeutic efficacy and safety profiles, making it a critical reagent for researchers investigating PARP inhibition in cancer therapy. -
Drug Impurity
Everolimus impurity 11 is a chemical impurity associated with the mTOR inhibitor Everolimus. This impurity is essential for evaluating the quality and stability of Everolimus formulations in pharmaceutical research. It plays a crucial role in ensuring compliance with regulatory standards and understanding the compound's behavior in biological systems. Researchers may utilize this impurity for analytical characterization and to study its potential effects on mTOR signaling pathways. -
Drug Impurity
Apixaban impurity 14 is a known impurity associated with Apixaban, an anticoagulant used for the prevention of thromboembolic events. This reagent can be utilized to assess the purity of Apixaban formulations and support quality control measures in pharmaceutical development. Its detection and characterization are critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Aripiprazole impurity 3 is a synthetic byproduct associated with the antipsychotic agent Aripiprazole. This compound serves as a valuable tool for quality control and analysis in pharmaceutical research, particularly in the development and purification processes of Aripiprazole. Its characterization aids in ensuring the safety and efficacy of formulations containing the active drug. -
Drug Impurity
Flecainide Impurity 2 is a known impurity of the antiarrhythmic agent Flecainide. This compound serves as a reference standard for the quality control and characterization of Flecainide formulations. Its identification and quantification are critical in ensuring the purity and consistency of pharmaceutical products containing Flecainide, making it essential for research and development in medicinal chemistry and analytical chemistry applications. -
Drug Impurity
Azithromycin impurity 1 is a recognized impurity variant of the antibiotic Azithromycin. This compound serves as a critical reference standard for quality control and analytical testing in drug formulation. Its characterization is essential for ensuring the purity and efficacy of Azithromycin in pharmaceutical applications and contributes to the understanding of its stability and degradation pathways. -
Drug Impurity
Ranitidine impurity 8 is a recognized impurity associated with the drug Ranitidine. It serves as a critical reference standard for the analytical evaluation of Ranitidine formulations, ensuring compliance with regulatory specifications. This compound is essential for quality control and stability testing in pharmaceutical research, providing valuable insights into the drug's purity and safety profile. -
Drug Impurity
Trazodone Impurity 8 is a synthetic impurity associated with the drug Trazodone, primarily a serotonin antagonist and reuptake inhibitor. This compound is utilized in research to study the pharmacological effects and safety profiles of Trazodone, aiding in the assessment of drug quality and compliance in pharmaceutical formulations. Its presence can provide insights into metabolic pathways and potential side effects, making it valuable for drug development and regulatory analysis. -
Drug Impurity
Diclofenac impurity 5 is a chemical impurity associated with Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID). This impurity can be of interest in pharmacokinetic studies and quality control processes due to its potential effects on the drug's safety and efficacy. Research applications include analysis of drug formulations, stability testing, and assessment of the impurity's impact on pharmacological activity. -
Drug Impurity
Abacavir impurity 5, known as trans-Abacavir Hydrochloride, is a specific impurity associated with the antiviral medication Abacavir. It is primarily used in pharmaceutical research and quality control to ensure the purity and safety of Abacavir formulations. This compound serves as a reference standard for the analysis and identification of impurities in drug development processes. -
Drug Impurity
Clarithromycin impurity 4, also known as N-Desmethyl Clarithromycin, functions as a drug impurity of Clarithromycin. This compound is utilized primarily for method development and validation in the analysis of Clarithromycin and its related substances. It aids in assessing the purity and quality of pharmaceutical formulations. -
Drug Impurity
Tipiracil Impurity 1 is a known impurity of the chemotherapeutic agent Tipiracil, which acts as a thymidine phosphorylase inhibitor. This impurity is significant in drug development and quality control processes, helping to ensure the purity and safety of pharmaceutical formulations containing Tipiracil. Its characterization is crucial for understanding the drug's profile and potential impacts in therapeutic applications. -
Drug Impurity
Azithromycin impurity 3, also known as 2-Desethyl-2-propylazithromycin, is a drug impurity associated with Azithromycin. This compound serves as a reference standard for analytical studies and is essential for the quality control of Azithromycin formulations. It is commonly utilized in research applications focused on the identification and quantification of impurities in pharmaceutical products. -
Drug Impurity
Domperidone impurity 1 is a significant impurity of the antiemetic medication Domperidone. As a byproduct of the drug's synthesis, it serves as an important reference for quality control and method development in pharmaceutical research. This reagent is essential for analytical studies to ensure the purity and compliance of Domperidone formulations in pharmaceutical applications. -
Drug Impurity
Haloperidol impurity 2 is a chemical impurity associated with the antipsychotic agent Haloperidol. This compound is primarily used for research applications to assess the purity and stability of Haloperidol formulations. Its presence in pharmaceutical development is critical for quality control and ensuring compliance with regulatory requirements. -
Drug Impurity
Alfuzosin EP impurity 2, also known as N2-Methyl alfuzosin, is a recognized impurity associated with the pharmaceutical compound Alfuzosin. This chemical structure serves as a valuable reference in the evaluation of drug purity and quality control in pharmaceutical research. It is useful for studies related to the pharmacokinetics and safety assessment of alfuzosin-based formulations. -
Drug Impurity
Mirabegron impurity 6 is a recognized impurity of the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. It serves as an important reference standard for quality control in the synthesis and analysis of Mirabegron and is crucial in ensuring the purity and efficacy of the drug. This impurity can assist in research applications involving pharmacokinetics, safety assessments, and metabolic studies of β3-adrenergic modulators. -
Drug Impurity
Albendazole impurity 4 is a chemical impurity associated with the antifungal agent Albendazole, which primarily targets helminthic diseases. This impurity can be utilized in pharmacological research to assess the purity of Albendazole formulations and to study its degradation products. It plays an important role in quality control and regulatory compliance during drug development. -
Drug Impurity
Azithromycin impurity 5, also known as Azithromycin B, is a degradation product of Azithromycin. This impurity is relevant for quality control and analytical studies in pharmaceutical research. It can provide insights into the stability and integrity of Azithromycin formulations, aiding in the evaluation of drug purity and efficacy. -
Drug Impurity
Febuxostat impurity 12 is a chemical impurity associated with Febuxostat, a selective inhibitor of xanthine oxidase. This compound is important for analytical and quality control purposes in pharmaceutical research, particularly in the assessment of the purity of Febuxostat formulations. It serves as a reference standard for the identification and quantification of impurities during drug development and testing stages. -
Drug Impurity
Roxithromycin impurity 6 is a synthetic impurity associated with Roxithromycin, a macrolide antibiotic. This compound is vital for quality control and analytical research in pharmaceutical development, aiding in the characterization and assessment of Roxithromycin formulations. Understanding such impurities is crucial for ensuring drug safety and efficacy in clinical applications. -
Drug Impurity
Ethinylestradiol impurity 1, also known as 9,11-Dehydro ethynyl estradiol, is a derivative and impurity of the synthetic estrogen Ethinylestradiol. This compound is used primarily as a reference standard in the quality control of pharmaceutical formulations containing Ethinylestradiol. Its presence can affect the overall efficacy and safety profiles of estrogen-based therapies, making it critical for analytical testing in drug development and regulatory compliance. -
Drug Impurity
Levothyroxine impurity 13 is a drug impurity associated with Levothyroxine. This compound is primarily used for analytical purposes in pharmaceutical research to ensure the purity and quality of Levothyroxine formulations. Its presence and characterization are crucial for regulatory compliance and the development of safer therapeutic agents. -
Drug Impurity
Rifampicin Impurity 1 is a known impurity associated with Rifampicin, a potent antibiotic targeting bacterial RNA polymerase. This compound is primarily utilized in pharmaceutical research to assess the purity of Rifampicin formulations and ensure compliance with quality standards. Its presence may influence the efficacy and safety profile of Rifampicin, making it a valuable reagent for analytical chemistry and regulatory studies in drug development. -
Drug Impurity
Citalopram impurity 7 is a known impurity associated with Citalopram, a selective serotonin reuptake inhibitor (SSRI). This compound is useful for analytical purposes in the development and quality control of pharmaceutical formulations containing Citalopram. It aids in understanding the stability, degradation pathways, and overall purity of the drug within research applications. -
Drug Impurity
Fenirofibrate impurity 7 is a chemical impurity associated with Fenirofibrate. This compound can be used for analytical purposes in pharmacological research and quality control of pharmaceutical formulations. It is essential for understanding the pharmacokinetics and safety profile of Fenirofibrate, aiding in the assessment of drug purity and stability. -
Drug Impurity
Levetiracetam impurity 2, also known as Levetiracetam dehydro acid, is a chemical impurity associated with the anticonvulsant drug Levetiracetam. It plays a role in the assessment of drug quality and stability during pharmaceutical analysis. This compound is essential for researchers investigating the pharmacological properties and potential effects of impurities in drug formulations. -
Drug Impurity
Edoxaban impurity 18 is a chemical impurity associated with Edoxaban, an oral anticoagulant that targets factor Xa in the coagulation cascade. This impurity is critical for the assessment of drug purity and stability in pharmaceutical research and development. It serves as a valuable reference standard for the analysis and quality control of Edoxaban formulations. -
Drug Impurity
Rivaroxaban impurity 31 is a known impurity associated with the anticoagulant agent Rivaroxaban, functioning primarily as a drug impurity. This compound is utilized for analytical purposes in pharmaceutical research, particularly in the assessment of drug purity and the development of quality control methods. It may play a crucial role in stability studies and impurity profiling in pharmacological formulations. -
Drug Impurity
Rivaroxaban impurity 7 is a known impurity associated with Rivaroxaban, a selective factor Xa inhibitor. This compound is utilized primarily in the quality control and analytical characterization of Rivaroxaban formulations. Its presence and quantification are crucial for ensuring the purity and safety of pharmaceutical products containing Rivaroxaban. -
Drug Impurity
Cetirizine Impurity 12 is a chemical impurity associated with Cetirizine, an antihistamine commonly used for allergy relief. This compound serves as a reference standard for analytical studies, including stability testing and quality control in pharmaceutical formulations. Its evaluation is crucial for ensuring the purity and safety of Cetirizine in drug development and manufacturing processes. -
Drug Impurity
(R)-Citalopram is a stereoisomer of the selective serotonin reuptake inhibitor (SSRI) citalopram, typically investigated as a drug impurity. It may exhibit biological activity associated with serotonergic pathways, providing insights into pharmacological effects and safety profiles of citalopram formulations. This compound can serve as a valuable reference standard in quality control and pharmacokinetic studies. -
Drug Impurity
Tamsulosin impurity 15 is a chemical impurity associated with the pharmaceutical compound Tamsulosin, which primarily targets alpha-1 adrenergic receptors. This impurity is relevant for quality control and characterization in the development and analysis of Tamsulosin formulations. Research applications include assessing the purity and safety profiles of Tamsulosin in pharmaceutical formulations. -
Drug Impurity
Apixaban 4,5-dehydro carboxylic acid ethyl ester is a known drug impurity associated with the anticoagulant Apixaban. This impurity may influence the pharmacokinetic and pharmacodynamic profiles of the parent compound, making it relevant for bioanalytical studies and quality control during drug development. Researchers can utilize this compound to investigate the stability and degradation pathways of Apixaban, as well as to assess the potential impacts of impurities on therapeutic efficacy. -
Drug Impurity
Atorvastatin impurity 6 sodium, also known as Atorvastatin lactam impurity sodium, is a pharmaceutical impurity related to Atorvastatin sodium. This compound serves as a critical reference standard in the analysis of drug substances and quality control processes. Its characterization is essential for ensuring compliance with regulatory standards and for studying the stability and safety profiles of atorvastatin-related pharmaceuticals. -
Drug Impurity
Hydrocortisone impurity 6, also known as 21-Dehydrocortisol, is a recognized impurity of hydrocortisone. This compound is significant in the study of drug purity and stability, serving as a reference standard for analytical methods in pharmaceutical research. Its evaluation helps in understanding the degradation pathways of hydrocortisone and assessing the quality of pharmaceutical formulations. -
Drug Impurity
Sertraline impurity 11 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) sertraline. This compound is critical for analytical and quality control processes in pharmaceutical research, enabling accurate assessment of sertraline's purity and formulation stability. Its characterization is essential for regulatory compliance and the development of robust analytical methods in drug formulation studies. -
Drug Impurity
Carvedilol impurity 5 is a known impurity of the β-blocker carvedilol. This compound is significant for researchers assessing the purity of carvedilol formulations and studying its pharmacokinetics. Understanding this impurity can aid in the development of more effective and safer cardiovascular therapies. It serves primarily in quality control processes and analytical method development within pharmaceutical research. -
Drug Impurity
Duloxetine impurity 8 hydrochloride is a characterized impurity of Duloxetine hydrochloride, primarily serving as a reference standard in analytical and quality control applications. This compound is critical for evaluating the purity of Duloxetine formulations and ensuring compliance with regulatory standards. It aids in the development and stability testing of pharmaceutical products containing Duloxetine. -
Drug Impurity
N-(2,6-dimethylphenyl)-2-(ethyl(methyl)amino)acetamide hydrochloride is a recognized impurity associated with the sodium channel inhibitor Lidocaine. This compound may serve as a reference standard for quality control and analytical studies within pharmacological research. It can aid in the assessment of drug purity and the validation of analytical methods used in drug development and manufacturing processes. -
Drug Impurity
Tamsulosin impurity 1 is a chemical impurity associated with the pharmaceutical agent Tamsulosin. It is primarily used in the analysis of drug purity and quality control in pharmaceutical research and development. Its presence can be critical in understanding the pharmacological properties and safety profile of Tamsulosin, facilitating regulatory compliance and ensuring therapeutic efficacy. This impurity serves as an important reference standard in analytical studies.
